WH
ABBV icon

Willner & Heller’s AbbVie ABBV Stock Holding History

Willner & Heller’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Buy
5,852
+43
+0.7% +$9.25K 0.92% 27
2026
Q1 		$1.26M Sell
5,809
-6
-0.1% -$1.33K 0.94% 27
2025
Q4 		$1.33M Sell
5,815
-1,781
-23% -$406K 0.95% 24
2025
Q3 		$1.76M Buy
7,596
+46
+0.6% +$9.37K 1.35% 12
2025
Q2 		$1.4M Sell
7,550
-864
-10% -$161K 1.18% 20
2025
Q1 		$1.76M Sell
8,414
-34
-0.4% -$6.61K 1.63% 11
2024
Q4 		$1.5M Buy
8,448
+491
+6% +$90.3K 1.32% 14
2024
Q3 		$1.57M Sell
7,957
-25
-0.3% -$4.67K 1.4% 12
2024
Q2 		$1.37M Buy
7,982
+77
+1% +$12.8K 1.31% 14
2024
Q1 		$1.44M Sell
7,905
-57
-0.7% -$9.82K 1.43% 12
2023
Q4 		$1.23M Buy
+7,962
New +$1.16M 1.38% 13
2022
Q4 		$1.21M Sell
7,465
-119
-2% -$18.2K 1.71% 8
2022
Q3 		$1.02M Buy
7,584
+275
+4% +$39.5K 1.64% 10
2022
Q2 		$1.12M Sell
7,309
-180
-2% -$27.5K 1.74% 8
2022
Q1 		$1.01M Buy
7,489
+82
+1% +$11.9K 1.25% 16
2021
Q4 		$799K Buy
+7,407
New +$875K 1.06% 21

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Willner & Heller's ABBV Position: Q2 2026 in Review

Willner & Heller increased its AbbVie (ABBV) stake by 0.74% in Q2 2026, buying an estimated $9.25K and bringing the position to 5,852 shares worth $1.47M. The position accounts for 0.92% of the portfolio, ranked #27.

Willner & Heller first reported a position in ABBV in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.76M in Q1 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Willner & Heller held 5,852 shares of AbbVie worth $1.47M as of Q2 2026.
  • Willner & Heller bought 43 AbbVie shares in Q2 2026, an estimated $9.25K.
  • AbbVie made up 0.92% of Willner & Heller's portfolio in Q2 2026, its #27 holding.
  • Willner & Heller first reported a position in AbbVie in Q4 2021 and has held it in 16 quarters since.
  • Willner & Heller's AbbVie position peaked at $1.76M in Q1 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Willner & Heller's 13F filing for Q2 2026, filed 7 Jul 2026.